The ONLY orthopedic-related company to pursue the public markets since Monogram (2023) and Treace (2021) is HingeHealth - https://www.hingehealth.com/
On March 10, 2025, Hinge Health’s S-1 filing went live, signaling its intent to pursue an IPO under the ticker symbol $HNGE. Hinge Health specializes in digital health solutions for musculoskeletal (MSK) conditions, offering virtual physical therapy, wearable sensors, and personalized treatment plans—technologies that align with orthopedic care by addressing joint and muscle issues non-surgically. While not a traditional orthopedic implant manufacturer, its focus on MSK health positions it within the broader orthopedic medical device ecosystem.
Reported Sales (Revenue)
2023 Revenue: $292 million
2024 Revenue: $390 million
Read the S-1 Filing
Hinge Health Files Registration Statement for Proposed Initial Public Offering (press release)
SAN FRANCISCO – March 10, 2025 – Hinge Health announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its Class A common stock. The number of shares to be offered and the pr...
